Tuesday, October 13, 2020 11:47:50 AM
Speculative post here, also shared on Twitter lol, but Tiggeriffic shared something interesting that maybe deserves to be looked at again in consideration with the Inhaled version of RLF ....
Could Nephron’s “Atomizer” perhaps be the method of delivery here for “long-haulers” with symptoms if efficacy is shown there? Curiously named “E-100”..... Not saying it’s by any means ready to go but just doing some dot connecting here, since Nephron is supposed to be rolling out the inhaled version as per PR linked below??
https://www.nephronpharm.com/products/ez-breathe-atomizer
“The development partners, NeuroRx and Relief, are leading US and EU commercialization plans, respectively. They have now contracted with Nephron Pharmaceuticals, Inc. to manufacture commercial supplies of RLF-100™, in order to ensure that adequate drug inventory will be immediately available, should the clinical trials demonstrate safety and efficacy.”
Taken from Sept. 30 PR:
https://www.prnewswire.com/news-releases/neurorx-and-relief-therapeutics-establish-supply-and-distribution-agreements-for-rlf-100-aviptadil-301140389.html
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM